Your browser doesn't support javascript.
loading
The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.
Ostrowski, Philip J; Zachariou, Anna; Loveday, Chey; Beleza-Meireles, Ana; Bertoli, Marta; Dean, John; Douglas, Andrew G L; Ellis, Ian; Foster, Alison; Graham, John M; Hague, Jennifer; Hilhorst-Hofstee, Yvonne; Hoffer, Mariette; Johnson, Diana; Josifova, Dragana; Kant, Sarina G; Kini, Usha; Lachlan, Katherine; Lam, Wayne; Lees, Melissa; Lynch, Sally; Maitz, Silvia; McKee, Shane; Metcalfe, Kay; Nathanson, Katherine; Ockeloen, Charlotte W; Parker, Michael J; Pierson, Tyler M; Rahikkala, Elisa; Sanchez-Lara, Pedro A; Spano, Alice; Van Maldergem, Lionel; Cole, Trevor; Douzgou, Sofia; Tatton-Brown, Katrina.
Afiliación
  • Ostrowski PJ; South West Thames Regional Genetics Service, St George's University NHS Foundation Trust, London, UK.
  • Zachariou A; Division of Clinical Studies, Institute of Cancer Research, London, UK.
  • Loveday C; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Beleza-Meireles A; Clinical Genetics Department, Guy's and St. Thomas NHS Trust, London, UK.
  • Bertoli M; Northern Genetics Service, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Dean J; North of Scotland Medical Genetic Service, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Douglas AGL; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Ellis I; Human Development and Health, Duthie Building, University of Southampton, Southampton, UK.
  • Foster A; Department of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
  • Graham JM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Hague J; West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Hilhorst-Hofstee Y; David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, California.
  • Hoffer M; Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California.
  • Johnson D; East of England Regional Medical Genetics Service, Addenbrooke's Hospital, Cambridge, UK.
  • Josifova D; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
  • Kant SG; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
  • Kini U; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Lachlan K; Clinical Genetics Department, Guy's and St. Thomas NHS Trust, London, UK.
  • Lam W; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
  • Lees M; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Lynch S; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Maitz S; Department of Clinical Genetics, Western General Hospital, Edinburgh, UK.
  • McKee S; Clinical Genetics Unit, Great Ormond Street Hospital, London, UK.
  • Metcalfe K; Temple Street Children's Hospital, Dublin, Ireland.
  • Nathanson K; Pediatric Genetics Unit, MBBM Foundation, S. Gerardo Hospital, Monza, Italy.
  • Ockeloen CW; Northern Ireland Regional Genetics Centre, Belfast Health and Social Care Trust, Belfast City Hospital, Belfast, UK.
  • Parker MJ; Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Pierson TM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Rahikkala E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Sanchez-Lara PA; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Spano A; Department of Pediatrics and Neurology, and the Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Van Maldergem L; Department of Clinical Genetics, PEDEGO Research Unit and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Cole T; David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, California.
  • Douzgou S; Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California.
  • Tatton-Brown K; Pediatric Genetics Unit, MBBM Foundation, S. Gerardo Hospital, Monza, Italy.
Am J Med Genet C Semin Med Genet ; 181(4): 557-564, 2019 12.
Article en En | MEDLINE | ID: mdl-31721432
ABSTRACT
CHD8 has been reported as an autism susceptibility/intellectual disability gene but emerging evidence suggests that it additionally causes an overgrowth phenotype. This study reports 27 unrelated patients with pathogenic or likely pathogenic CHD8 variants (25 null variants, two missense variants) and a malefemale ratio of 216 (3.51, p < .01). All patients presented with intellectual disability, with 85% in the mild or moderate range, and 85% had a height and/or head circumference ≥2 standard deviations above the mean, meeting our clinical criteria for overgrowth. Behavioral problems were reported in the majority of patients (78%), with over half (56%) either formally diagnosed with an autistic spectrum disorder or described as having autistic traits. Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma (≤15% each). These results suggest that, in addition to its established link with autism and intellectual disability, CHD8 causes an overgrowth phenotype, and should be considered in the differential diagnosis of patients presenting with increased height and/or head circumference in association with intellectual disability.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fenotipo / Cadherinas / Trastornos del Crecimiento Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Am J Med Genet C Semin Med Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fenotipo / Cadherinas / Trastornos del Crecimiento Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Am J Med Genet C Semin Med Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido